National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

flutamide
A toluidine derivative and nonsteroidal antiandrogen that is structurally related to bicalutamide and nilutamide. Flutamide and its more potent active metabolite 2-hydroxyflutamide competitively block dihydrotestosterone binding at androgen receptors, forming inactive complexes which cannot translocate into the cell nucleus. Formation of inactive receptors inhibits androgen-dependent DNA and protein synthesis, resulting in tumor cell growth arrest or transient tumor regression. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:Flucinom
Flugerel
Niftolid
US brand name:Eulexin
Foreign brand names:Apimid
Chimax
Drogenil
Euflex
Eulexine
Flucinome
Fluken
Flulem
Flutabene
Flutacan
Fluta-Gry
Flutamex
Flutamin
Flutan
Flutaplex
Fugerel
Grisetin
Oncosal
Profamid
Prostacur
Prostadirex
Prostica
Prostogenat
Tafenil
Tecnoflut
Testotard
Abbreviation:FLUT
Code name:Sch 13521
Chemical structure names:
  • 2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
  • 4'-nitro-3'-trifluoromethylisobutyranilide
  • alpha,alpha,alpha-trifluoro-2-methy-4'-nitro-m-propionotoluidide



Previous:fluoxymesterone, fluphenazine hydrochloride, flurbiprofen, Flurizan, Flushield
Next:fluvastatin sodium, Fluvirin, Fluzone, folate receptor-targeted epothilone BMS753493, folate receptor-targeted technetium Tc 99m EC20

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov